HedgeChatter

  • Home /
  • Tag Archives

AMRN

Amarin Announces $100 Million Non-Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives

[at noodls] – Steps Are Consistent With Amarin’s Continuation of Its Strategy to Parallel Process Three Strategic Options Conference Call Scheduled for Today, December 6th at 4:30 p.m. ET BEDMINSTER, N.J., and DUBLIN, … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

December 6, 2012 Bystocknews , Comments Off on Amarin Announces $100 Million Non-Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives read more

Amarin Announces U.S. Patent 8,314,086 Issuance for Vascepa(R)

[at noodls] – BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 20, 2012 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboard […]

November 20, 2012 Bystocknews , Comments Off on Amarin Announces U.S. Patent 8,314,086 Issuance for Vascepa(R) read more

PropThink: No Launch Yet for AMRN’s Vascepa is Good News; NCE Decision Is The Next Key Event

[ACN Newswire] – By David MoskowitzEarnings for Amarin Corp. (NASDAQ:AMRN) were primarily focused on the company’s strategy for the launch of Vascepa, as well as the FDA’s decision on whether the newly approved product … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboard […]

November 9, 2012 Bystocknews , Comments Off on PropThink: No Launch Yet for AMRN’s Vascepa is Good News; NCE Decision Is The Next Key Event read more

Amarin Reports Third Quarter 2012 Financial Results and Provides Update on Operations

[at noodls] – Conference Call Set for 4:30 p.m. EST Today BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 8, 2012 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboard […]

November 8, 2012 Bystocknews , Comments Off on Amarin Reports Third Quarter 2012 Financial Results and Provides Update on Operations read more

Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012

[at noodls] – Conference Call Set for 4:30 p.m. ET on November 8th BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 1, 2012 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboard […]

November 8, 2012 Bystocknews , Comments Off on Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012 read more